Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Systemic Anti Cancer Therapy

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

This public procurement record has 2 releases in its history.

TenderUpdate

23 Jul 2026 at 12:33

Tender Notice
Award

10 Jul 2026 at 11:47

Award Notice
Summary of the contracting process

The Newcastle Upon Tyne Hospitals NHS Foundation Trust procured systemic anti-cancer therapy, classified as health services. The requirement concerns the provision of systemic anti-cancer treatment as a healthcare service for the Trust, with activity associated with Newcastle upon Tyne and the surrounding delivery area recorded for the requirement. The Trust is the buyer and healthcare organisation responsible for the procurement. The selected provider is Lloyds Clinical Limited, a large supplier based in Harlow, Essex. This is a specialist healthcare opportunity rather than a general medicines supply contract: relevant businesses are those able to provide systemic anti-cancer therapy services and work within the Trust’s clinical and operational arrangements.

The procurement has reached completion: Lloyds Clinical Limited received the active award, and the contract was signed on 1 April 2026. The award followed a limited procedure without prior publication of a competition notice, under the Health Care Services (Provider Selection Regime) Regulations 2023 rather than the Procurement Act 2023. One bid was recorded, with a valid bid value of £450,566.40; this was both the lowest and highest valid bid value. The single lot is recorded as cancelled, while the associated award and contract are active. The provider passed all five assessment criteria: quality and innovation; value; integration, collaboration and service sustainability; improving access, reducing inequalities and facilitating choice; and social value. The assessment considered previous performance and likely delivery against the proposed contract.

For suppliers that did not win, this award demonstrates demand from the Trust for a complete systemic anti-cancer therapy service delivered through the Provider Selection Regime. A credible future competitor would need to show strong clinical service quality, innovation and value, alongside the ability to integrate with the Trust and collaborate with relevant healthcare partners. Evidence of sustainable service delivery, improved patient access, reduced inequalities and meaningful patient choice would be important. The assessment also included social value, so suppliers should be able to explain the wider benefits of their delivery model. Previous performance against a comparable contract was considered, making relevant experience, reliable operations and evidence that the proposed service can meet required standards commercially important.

How relevant is this notice?

Notice Information

Notice Title

Systemic Anti Cancer Therapy

Notice Description

Systemic Anti Cancer Therapy

Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on 13th July 2026. Representations by providers must be made to the relevant authority by the end of standstill.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06c857
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/069659-2026
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
23 Jul 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
NEWCASTLE-UPON-TYNE
Postcode
NE7 7DN
Postcode Area
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
TLC22 Tyneside
Local Authority
Newcastle upon Tyne
Electoral Ward
Dene & South Gosforth
Westminster Constituency
Newcastle upon Tyne North

Supplier Information

Number of Suppliers
1
Supplier Name

LloydsPharmacy Clinical Homecare

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...